Trending

Are you looking for a stock?

Try one of these

U.S. News

Is Valeant Bill Ackman’s 'Waterloo?'
At least one money manager isn't buying Bill Ackman’s claims to have cleaned up the situation at Valeant, the troubled pharmaceutical company.
Posted on 5-12-2016 at 12:25 PM
Key player in Pershing Square's Valeant bet leaving firm
William Doyle, a key figure in Pershing Square Capital Management's controversial investment in battered drug company Valeant Pharmaceuticals, is leaving the hedge fund, its founder, William Ackman, told investors on Wednesday.
Posted on 5-12-2016 at 8:15 AM
Allergan profit beats, announces authorization of share buyback program of up to $10B
Allergan Plc whose $160 billion merger with Pfizer Inc fell apart last month, reported a better-than-expected quarterly profit on Tuesday, led by strong sales of wrinkle treatment Botox and eye drug Restasis.
Posted on 5-10-2016 at 11:28 AM
Krispy Kreme to be acquired by Germany's JAB for US$1.35B
Krispy Kreme Doughnuts Inc will be taken private by JAB Holding Co for about $1.35 billion, the second buyout of a U.S. food company by the German investment firm in just over two months.
Posted on 5-09-2016 at 9:44 AM
Valeant to file quarterly report by June 10, reiterates forecast
Valeant Pharmaceuticals said it expects to file its first-quarter report with U.S. and Canadian regulators on or before June 10, ahead of a July 31 deadline and reiterated its first-quarter forecasts.
Posted on 5-09-2016 at 11:59 AM
Canada's trade deficit widens to all-time record of $3.41 billion
Canada's trade deficit in March unexpectedly widened to a record $3.41 billion as exports sank for a second month on widespread weakness, Statistics Canada data indicated on Wednesday.
Posted on 5-04-2016 at 8:48 AM
Trump, the outrageous outsider, now presumptive Republican nominee
Billionaire reality TV star Donald Trump completed his transformation from long-shot White House candidate to presumptive Republican presidential nominee after his commanding win in Indiana's primary forced his main rival Ted Cruz to drop out of the race.
Posted on 5-04-2016 at 7:31 AM
Johnson & Johnson ordered to pay woman US$55M for talcum powder cancer link
Johnson & Johnson was ordered by a U.S. jury on Monday to pay $55 million to a woman who said that using the company’s talc-powder products for feminine hygiene caused her to develop ovarian cancer.
Posted on 5-03-2016 at 10:07 AM

News by Sector

Today's Guests
CTV.ca CTV Two CTV News CTV News Channel BNN - Business News Network CP24